![Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL](https://oncodaily.com/pub/uploads/2023/05/Hagop_Kantarjian__MD-e1713957952522.jpg)
Photo of Dr. Hagop Kantarjian from obroncology.com
May 19, 2024, 10:00
Hagop Kantarjian: A comprehensive review of ponatinib in CML and Ph+ ALL
Hagop Kantarjian, Leukaemia professor and Chair at MD Anderson Cancer Center, shared on X:
“A comprehensive review of the research history and current status of ponatinib in CML and Ph+ ALL
Elias Jabbour of MD Anderson Comprehensive Cancer Center.”
Source: Hagop Kantarjian/X